ADGI Announces Distribution Agreement With Cataldi Enterprise.HICKORY, N.C.--(BUSINESS WIRE)--Sept. 17, 1998--American Diversified Group (Nasdaq:ADGI) announced Thursday an agreement with Cataldi Enterprise Inc., a New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of corporation, having offices in Great Neck, N.Y. and related offices in Rio de Janeiro Rio de Janeiro, city, Brazil Rio de Janeiro (rē`ō də zhänā`rō, Port. rē`  thĭ zhənĕē`r , Brazil. Cataldi Enterprise has been granted the rights to represent ADGI, and distribute and sell ADGI's products, both in Brazil and internationally. Cataldi Enterprise will be instrumental in the process of securing the registration for ADGI of the Hepatitis B Hepatitis B Definition Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic vaccine--SHANVAC-B, manufactured by Shantha Biotechnics Shantha Biotechnics Ltd. is an Indian biotechnology company based in Hyderabad. Shantha Biotechnics is the first Indian company to develop, manufacture and market a recombinant human healthcare product in India. Pvt. Ltd. ADGI previously announced that Shantha has granted ADGI exclusive rights to distribute the SHANVAC-B vaccine, that prevents humans from contracting Hepatitis B, throughout South America South America, fourth largest continent (1991 est. pop. 299,150,000), c.6,880,000 sq mi (17,819,000 sq km), the southern of the two continents of the Western Hemisphere. , Asia and Africa. Cataldi Enterprise has developed a record of excellent performance and international sales expertise, world-wide, with respect to the distribution and sale of medical and pharmaceutical products, among others. For further information, ADGI's Broadcast Fax System provides ADGI information (releases, newsletters, shareholder updates) and is accessible to all ADGI shareholders via fax. To become part of ADGI's Broadcast System, please contact ADGI's Investor Relations Investor relations The process by which the corporation communicates with its investors. Office at 212/332-5009 or by fax at 212/332-3249. Except for the historical information herein, the matters discussed in this press release include forward-looking statements that may involve a number of risks and uncertainties. Actual results may vary based upon a number of factors, including, but not limited to, risks in product and technology development, market acceptance of new products and continuing demand, the impact of competitive products and pricing, changing economic conditions and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion